1. Home
  2. FPAY vs KALA Comparison

FPAY vs KALA Comparison

Compare FPAY & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FPAY
  • KALA
  • Stock Information
  • Founded
  • FPAY 2003
  • KALA 2009
  • Country
  • FPAY United States
  • KALA United States
  • Employees
  • FPAY N/A
  • KALA N/A
  • Industry
  • FPAY Diversified Commercial Services
  • KALA Biotechnology: Pharmaceutical Preparations
  • Sector
  • FPAY Consumer Discretionary
  • KALA Health Care
  • Exchange
  • FPAY Nasdaq
  • KALA Nasdaq
  • Market Cap
  • FPAY 27.2M
  • KALA 26.2M
  • IPO Year
  • FPAY N/A
  • KALA 2017
  • Fundamental
  • Price
  • FPAY $1.04
  • KALA $7.14
  • Analyst Decision
  • FPAY Strong Buy
  • KALA Strong Buy
  • Analyst Count
  • FPAY 2
  • KALA 3
  • Target Price
  • FPAY $3.25
  • KALA $14.00
  • AVG Volume (30 Days)
  • FPAY 96.0K
  • KALA 198.2K
  • Earning Date
  • FPAY 08-05-2025
  • KALA 08-05-2025
  • Dividend Yield
  • FPAY N/A
  • KALA N/A
  • EPS Growth
  • FPAY N/A
  • KALA N/A
  • EPS
  • FPAY N/A
  • KALA N/A
  • Revenue
  • FPAY $139,800,732.00
  • KALA N/A
  • Revenue This Year
  • FPAY $16.58
  • KALA N/A
  • Revenue Next Year
  • FPAY N/A
  • KALA N/A
  • P/E Ratio
  • FPAY N/A
  • KALA N/A
  • Revenue Growth
  • FPAY 19.51
  • KALA N/A
  • 52 Week Low
  • FPAY $0.84
  • KALA $2.92
  • 52 Week High
  • FPAY $2.37
  • KALA $11.20
  • Technical
  • Relative Strength Index (RSI)
  • FPAY 36.61
  • KALA 59.52
  • Support Level
  • FPAY $0.84
  • KALA $5.35
  • Resistance Level
  • FPAY $1.37
  • KALA $8.49
  • Average True Range (ATR)
  • FPAY 0.10
  • KALA 0.81
  • MACD
  • FPAY -0.00
  • KALA 0.17
  • Stochastic Oscillator
  • FPAY 9.30
  • KALA 57.01

About FPAY FlexShopper Inc.

FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: